Schroder Investment Management Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,366
| Closed | -$44K | – | 1235 |
|
|
2018
Q3 | $44K | Buy |
+2,366
| New | +$44K | ﹤0.01% | 1211 |
|
|
2018
Q2 | – | Sell |
-42,546
| Closed | -$1.21M | – | 1279 |
|
|
2018
Q1 | $1.21M | Sell |
42,546
-36,891
| -46% | -$1.05M | ﹤0.01% | 911 |
|
|
2017
Q4 | $1.68M | Buy |
79,437
+52,348
| +193% | +$1.11M | ﹤0.01% | 921 |
|
|
2017
Q3 | $489K | Buy |
+27,089
| New | +$489K | ﹤0.01% | 1078 |
|